APPLICATION
ANDA208366
TYPE
ANDA
ORIGINAL APPROVAL
2020-11-05
LATEST ACTION
2020-11-05
ROUTE
INTRAVENOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
MICAFUNGIN SODIUMDiscontinued
MICAFUNGIN SODIUM EQ 100MG BASE/VIAL · INJECTABLE · INTRAVENOUS
MICAFUNGIN SODIUMDiscontinued
MICAFUNGIN SODIUM EQ 50MG BASE/VIAL · INJECTABLE · INTRAVENOUS
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.